Share on StockTwits

Bodycote (LON:BOY)‘s stock had its “outperform” rating reaffirmed by research analysts at Credit Suisse in a report released on Monday, Stock Ratings reports. They currently have a GBX 760 ($12.52) price target on the stock. Credit Suisse’s target price points to a potential upside of 7.19% from the stock’s previous close.

A number of other firms have also recently commented on BOY. Analysts at Investec raised their price target on shares of Bodycote from GBX 750 ($12.36) to GBX 770 ($12.69) in a research note to investors on Monday. They now have a “buy” rating on the stock. Separately, analysts at Numis Securities Ltd downgraded shares of Bodycote to a “hold” rating in a research note to investors on Wednesday, January 8th. They now have a GBX 710 ($11.70) price target on the stock. Finally, analysts at N+1 Singer reiterated a “buy” rating on shares of Bodycote in a research note to investors on Monday, January 6th. They now have a GBX 700 ($11.54) price target on the stock. Three analysts have rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the stock. Bodycote has an average rating of “Hold” and an average price target of GBX 646.23 ($10.65).

Shares of Bodycote (LON:BOY) traded up 0.71% during mid-day trading on Monday, hitting GBX 714.00. The stock had a trading volume of 95,918 shares. Bodycote has a one year low of GBX 440.00 and a one year high of GBX 714.00. The stock has a 50-day moving average of GBX 639.2 and a 200-day moving average of GBX 630.3. The company’s market cap is £1.352 billion.

Bodycote plc (LON:BOY) is a specialized plasma spray, high velocity oxy fuel (HVOF) and thermally formed ceramic treatments.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.